Nataliya Agafonova
Net worth: 185 013 $ as of 2026-09-29
Net worth: 185 013 $ as of 2026-09-29
Dr. Nataliya Agafonova was previously employed as a Chief Medical Officer by Longeveron, Inc., a Senior Medical Director by Bristol Myers Squibb Co., and a Senior Medical Director by Otsuka Pharmaceutical Development & Commercialization, Inc. She received her doctorate degree from Bogomolets National Medical University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-30 | 68,778 ( 2.26% ) | 185 013 $ | 2026-09-29 |
| Companies | Position | End |
|---|---|---|
| LONGEVERON INC. | Chief Tech/Sci/R&D Officer | 2026-10-13 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | 2023-05-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Bogomolets National Medical University
Bogomolets National Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions